226 related articles for article (PubMed ID: 24402120)
1. The association between metabolic syndrome and hepatocellular carcinoma: systemic review and meta-analysis.
Jinjuvadia R; Patel S; Liangpunsakul S
J Clin Gastroenterol; 2014 Feb; 48(2):172-7. PubMed ID: 24402120
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome and liver-related events: a systematic review and meta-analysis.
Ren H; Wang J; Gao Y; Yang F; Huang W
BMC Endocr Disord; 2019 Apr; 19(1):40. PubMed ID: 31023282
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome relates to high risk in hepatocellular carcinoma: a meta-analysis.
Li Y; Shi J; Liu X; Deng Q; Huang Y; Yang Z
Discov Med; 2018 Nov; 26(144):185-196. PubMed ID: 30695678
[TBL] [Abstract][Full Text] [Related]
5. The association between metabolic syndrome and colorectal neoplasm: systemic review and meta-analysis.
Jinjuvadia R; Lohia P; Jinjuvadia C; Montoya S; Liangpunsakul S
J Clin Gastroenterol; 2013 Jan; 47(1):33-44. PubMed ID: 23090040
[TBL] [Abstract][Full Text] [Related]
6. Association between metabolic abnormalities and HBV related hepatocelluar carcinoma in Chinese: a cross-sectional study.
Zhao J; Zhao Y; Wang H; Gu X; Ji J; Gao C
Nutr J; 2011 May; 10():49. PubMed ID: 21569630
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome and hepatocellular carcinoma risk.
Turati F; Talamini R; Pelucchi C; Polesel J; Franceschi S; Crispo A; Izzo F; La Vecchia C; Boffetta P; Montella M
Br J Cancer; 2013 Jan; 108(1):222-8. PubMed ID: 23169288
[TBL] [Abstract][Full Text] [Related]
8. Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study.
Yu MW; Lin CL; Liu CJ; Yang SH; Tseng YL; Wu CF
Gastroenterology; 2017 Oct; 153(4):1006-1017.e5. PubMed ID: 28711626
[TBL] [Abstract][Full Text] [Related]
9. The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: A study in the Swedish AMORIS cohort.
Nderitu P; Bosco C; Garmo H; Holmberg L; Malmström H; Hammar N; Walldius G; Jungner I; Ross P; Van Hemelrijck M
Int J Cancer; 2017 Sep; 141(6):1148-1160. PubMed ID: 28577304
[TBL] [Abstract][Full Text] [Related]
10. Inverse Association of Coffee with Liver Cancer Development: An Updated Systematic Review and Meta-analysis.
Bhurwal A; Rattan P; Yoshitake S; Pioppo L; Reja D; Dellatore P; Rustgi V
J Gastrointestin Liver Dis; 2020 Sep; 29(3):421-428. PubMed ID: 32830818
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome in hematologic malignancies survivors: a meta-analysis.
Li C; Liu P; Liu L; Zhang X; Yang P; Sheng H; Bu L; Li H; Qu S
Med Oncol; 2015 Jan; 32(1):422. PubMed ID: 25471791
[TBL] [Abstract][Full Text] [Related]
12. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis.
Zhang H; Gao C; Fang L; Zhao HC; Yao SK
Scand J Gastroenterol; 2013 Jan; 48(1):78-87. PubMed ID: 23137049
[TBL] [Abstract][Full Text] [Related]
13. Highlights for α-fetoprotein in determining prognosis and treatment monitoring for hepatocellular carcinoma.
Xu XS; Qu K; Liu C; Zhang YL; Liu J; Song YZ; Zhang P; Liu SN; Chang HL
World J Gastroenterol; 2012 Dec; 18(48):7242-50. PubMed ID: 23326129
[TBL] [Abstract][Full Text] [Related]
14. Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.
Colli A; Nadarevic T; Miletic D; Giljaca V; Fraquelli M; Štimac D; Casazza G
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013346. PubMed ID: 33855699
[TBL] [Abstract][Full Text] [Related]
15. The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias?
Goodgame B; Shaheen NJ; Galanko J; El-Serag HB
Am J Gastroenterol; 2003 Nov; 98(11):2535-42. PubMed ID: 14638360
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma.
Weis S; Franke A; Berg T; Mössner J; Fleig WE; Schoppmeyer K
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD006745. PubMed ID: 25620061
[TBL] [Abstract][Full Text] [Related]
17. Insulin Resistance is Associated With Significant Liver Fibrosis in Chronic Hepatitis C Patients: A Systemic Review and Meta-Analysis.
Patel S; Jinjuvadia R; Patel R; Liangpunsakul S
J Clin Gastroenterol; 2016 Jan; 50(1):80-4. PubMed ID: 26302498
[TBL] [Abstract][Full Text] [Related]
18. The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies.
Yang WS; Va P; Bray F; Gao S; Gao J; Li HL; Xiang YB
PLoS One; 2011; 6(12):e27326. PubMed ID: 22205924
[TBL] [Abstract][Full Text] [Related]
19. Risk factors of cryptogenic hepatocellular carcinoma in patients with low body mass index or without metabolic syndrome.
Song HY; Lee HK; Lee JS; Kim JY; Yim YH; Song TJ; Bae WK; Kim NH; Kim KA
Korean J Intern Med; 2012 Mar; 27(1):47-52. PubMed ID: 22403499
[TBL] [Abstract][Full Text] [Related]
20. Association of circulating total bilirubin with the metabolic syndrome and type 2 diabetes: A systematic review and meta-analysis of observational evidence.
Nano J; Muka T; Cepeda M; Voortman T; Dhana K; Brahimaj A; Dehghan A; Franco OH
Diabetes Metab; 2016 Dec; 42(6):389-397. PubMed ID: 27396752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
